Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
Recruitment Status: Recruiting
Start Date: March 29, 2021
End Date: January 01, 2028
Inclusion Criteria:
- Patients 18 years and older
- Written informed consent (patient data release-form)
- Use of any commercially available Boston Scientific drug-eluting device marketed for treatment of lesions in the peripheral vasculature and specified in the Registry Enrollment Guide
Exclusion Criteria:
- Life expectancy of <1 year